Self-Collected HPV Test Results Are as Accurate as Clinic-Collected Results
Self-collected cervical samples showed sensitivity and accuracy similar to clinical collection in detecting HPV positivity and CIN 2 - CIN3 lesions.

In this article
In the IMPROVE study conducted by Polman and colleagues and published in THE LANCET Oncology, self-collected cervical (cervix) samples showed, for HPV positivity and HPV-related cervical intraepithelial neoplasia (CIN 2 or CIN3) lesions, sensitivity and accuracy similar to samples collected during a doctor’s examination.
Study Details
Women aged 29 to 61 were invited to participate as part of regular Dutch cancer screening . Participants were randomly divided equally into two arms: one used Evalyn Brush for self-collection of cervicovaginal samples; in the other, a physician used Cervex-Brush as usual.
All samples were tested for HPV using clinically validated GP5+/6+ polymerase chain reaction (PCR) . Women testing positive in either group were retested using the other collection method.
The figure below illustrates the pathological process from HPV infection to cervical cancer . CIN stands for cervical intraepithelial neoplasia and ranges from 1 to 3; increasing numbers indicate a greater proportion of dysplastic cells. CIN is not cancer and does not necessarily become cancer, but these lesions have cancerous potential (precancerous).

Related Topic:
The primary endpoints were detecting CIN2 and CIN3 positivity. Noninferiority (not being a weaker test) criteria for self-collected versus physician-collected samples were set at % 90 relative sensitivity and % 98 relative specificity.
Study Results
- Among 187.473 women invited, 8.212 were assigned to self-sampling and 8.198 to physician-based sampling. After excluding ineligible women and non-returned samples, the self-sampling group included 7.643 and physician-based sampling 6.282 women.
- HPV positivity was detected in 569 (%7.4) self-collected samples and 451 (%7.2) physician-collected samples.
- Median follow-up for HPV-positive women was 20 months.
- No difference in sensitivity or accuracy (specificity) was observed between physician and self-sampling HPV tests for CIN2 positivity. Similarly, no difference was observed for CIN3 positivity.
In conclusion, HPV testing using a clinically validated PCR-based test had similar accuracy in self-collected and physician-collected samples for CIN2 + or CIN3 + lesions. These findings suggest self-sampling could be used as a primary method in routine screening.
Sources
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
THE LANCET Oncology, 15 January 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.